Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05034575 · ClinicalTrials.gov registry record · NA
Eye Tracking in Laryngology
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05034575: Completed NA study, sponsored by Mayo Clinic.
NCT05034575 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05034575, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether eye-tracking technology can be used to differentiate the visual gaze patterns of experienced and novice laryngoscopists while reviewing prerecorded laryngeal videos with both normal and abnormal findings and to characterize any differences arising between level of training groups.
Primary Outcome
Defined as the temporary suspension of eye movement (80ms) on a specific point (≤ 30 pixels) within the field of view.
Interventions
- OTHER Eye Tracking Technology Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
What the finished NCT05034575 record still lists
NCT05034575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Eye Tracking Technology Sensor is the first listed.
NCT05034575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05034575 about?
NCT05034575 is a clinical study titled "Eye Tracking in Laryngology". The purpose of this study is to assess whether eye-tracking technology can be used to differentiate the visual gaze patterns of experienced and novice laryngoscopists while reviewing prerecorded laryngeal videos with both normal and abnormal findings and to characterize any differences arising betwe...
What is the current status of trial NCT05034575?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-06-29. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT05034575?
The interventions under investigation include: Eye Tracking Technology Sensor (OTHER).
Who is sponsoring clinical trial NCT05034575?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05034575's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI